201485-17-8,
Fmoc-Homocit-OH,
Fmoc-L-homocitrulline,
Fmoc-Hcit-OH,
Fmoc-HoCit-OH,
(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-6-ureidohexanoic acid,
Fmoc-Lys(carbamoyl)-OH,
MFCD00237387,
C22H25N3O5,
AK117094,
SCHEMBL4882849,
(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)-amino)-6-ureidohexanoic acid,
KS-00000KFM,
DTXSID00427177,
Fmoc-N-epsilon-carbamoyl-L-lysine,
ZINC2560801,
0339AB,
AKOS016010491,
AJ-40655,
AS-10030,
SC-10269,
AX8032537,
485F178,
J-013057,
N-alpha-(9-Fluorenylmethyloxycarbonyl)-L-homocitrulline,
(S)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-6-ureidohexanoic acid,
L-Lysine, N6-(aminocarbonyl)-N2-[(9H-fluoren-9-ylmethoxy)carbonyl]-,
(2S)-6-(carbamoylamino)-2-(9H-fluoren-9-ylmethoxycarbonylamino)hexanoic acid,
CID7019813,
(2R)-6-(carbamoylamino)-2-(9H-fluoren-9-ylmethoxycarbonylamino)hexanoic Acid,